SCHEMBL12264347

SCHEMBL12264347

O=Cc1c[nH]nc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18517969 0.73
SCHEMBL9132195 0.73
SCHEMBL8407888 0.71
SCHEMBL1702959 0.71
SCHEMBL3451735 0.68 MEN1 (0.33)
SCHEMBL14836334 0.67 HCAR2 (0.38)
SCHEMBL13066107 0.67
SCHEMBL4707234 0.67 TYR (0.32)
SCHEMBL1144780 0.67
SCHEMBL16057764 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240182426-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. 2024-06-06 US disclosed
US-11512053-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2022-11-29 US disclosed
CN-109265400-B Arginine methyltransferase inhibitors and uses thereof EPIZYME股份有限公司 2022-10-04 CN disclosed
US-11185531-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2021-11-30 US disclosed
US-20210078951-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. 2021-03-18 US disclosed
US-20210078951-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. 2021-03-18 US disclosed
US-10800743-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2020-10-13 US disclosed
US-10800743-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2020-10-13 US disclosed
EP-2970132-B1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF EPIZYME INC (US) 2020-09-23 EP disclosed
EP-2970132-B1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF EPIZYME INC (US) 2020-09-23 EP disclosed
WO-2014153172-A1 PYRAZOLE DERIVATIVES AS PRMT1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
WO-2014153208-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
WO-2014153226-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
WO-2014153226-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
WO-2014153214-A1 ARGININE METHYL TRANSFERASE INHIBTORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
WO-2014153090-A1 PYRAZOLE DERIVATIVES ASPRMT1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 WO disclosed
US-20140288140-A1 PRMT1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-25 US disclosed
WO-2014144659-A1 PYRAZOLE DERIVATIVES AS PRMT1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-09-18 WO disclosed
EP-2376486-B1 NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMACEUTICALS SA (CH) 2013-11-06 EP disclosed
US-20110263610-A1 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2011-10-27 US disclosed